Education
About Us
Working with TipRanks
Follow Us
Jennifer E. Cook Insider Profile
4 Followers
Jennifer E. Cook, Director at Denali Therapeutics, holds 10.84K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 13.74K shares in BridgeBio Pharma (Ticker: BBIO), holds 26.07K shares in Denali Therapeutics (Ticker: DNLI).
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+6.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer E. Cook holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 15, 2023 - Aug 15, 2024
Return:+21.40%
The most profitable trade made by Jennifer E. Cook
Jennifer E. Cook's Trading History
Denali Therapeutics
Jun 05, 2025
Director
Uninformative Buy
―
$552.27K
BridgeBio Pharma
Jun 24, 2025
Director
Uninformative Buy
―
$913.50K
Jazz Pharmaceuticals
Aug 11, 2025
Director
Uninformative Buy
―
$2.06M
List of latest transactions for each holding click on a transaction to see Jennifer E. Cook's performance on stock
You May Also Like
Jennifer E. Cook insider profile FAQ
What is the percentage of profitable transactions made by Jennifer E. Cook?
The percentage of profitable transactions made by Jennifer E. Cook is 60%.
What is the average return per transaction made by Jennifer E. Cook?
The average return per transaction made by Jennifer E. Cook is 6.20%.
What stocks does Jennifer E. Cook hold?
Jennifer E. Cook holds: DNLI, BBIO, JAZZ stocks.
What was Jennifer E. Cook’s latest transaction?
Jennifer E. Cook latest transaction was an Uninformative Buy of ―.
What was Jennifer E. Cook's most profitable transaction?
Jennifer E. Cook’s most profitable transaction was an Informative Sell of JAZZ stock on August 15, 2023. The return on the trade was 21.40%.
What is Jennifer E. Cook's role in Denali Therapeutics?
Jennifer E. Cook's role in Denali Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.